CDRH Report: 24 Voluntary Diversity Action Plans Filed In 2024

Diversity paper cutouts
Sponsors' clinical trial diversity action plans would benefit from FDA feedback, industry groups said. • Source: Shutterstock

More from Medtech Insight

More from ESG